Venous thromboembolism is a product in proliferation of cancer cells

被引：0
作者：
Wang, Le-Min [1 ]
Duan, Qiang-Lin [1 ]
Yi, Xiang-Hua [2 ]
Zeng, Yu [2 ]
Gong, Zhu [1 ]
Yang, Fan [3 ]
机构：
[1] Tongji Univ, Sch Med, Dept Cardiol, Tongji Hosp, Shanghai 200065, Peoples R China
[2] Tongji Univ, Sch Med, Dept Pathol, Tongji Hosp, Shanghai 200065, Peoples R China
[3] Tongji Univ, Sch Med, Dept Lab Med, Tongji Hosp, Shanghai 200065, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2014年 / 7卷 / 05期
关键词：
Venous thromboembolism; cancer; filter; PULMONARY-EMBOLISM; THROMBOSIS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The pathogenesis of venous thromboembolism (VTE) in patients with cancer is related to the destruction of small veins and the intravenous formation of filamentous mesh-like structure by fibrinogen. The filamentous mesh-like filter can block hematogenous metastasis of cancer cells and also can stagnate blood cells, leading to venous thrombosis. Cancer cells have characteristics of malignancy and fast proliferation, and ischemic necrosis frequently occurs, and small veins were invaded and damaged. The formation of filamentous mesh-like structure has defense function and also may cause the occurrence of VTE. VTE is a product of the proliferation process of malignant cells.
引用
收藏
页码：1319 / 1323
页数：5
相关论文
共 50 条
  • [31] Cancer related venous thromboembolism - prophylaxis and therapy
    Gary, Thomas
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2014, 43 (04) : 245 - 251
  • [32] Prognosis of patients with venous thromboembolism and cancer in India
    Chukka, Kereena
    Sharma, Pritee
    Ramnadh, Satyendra G.
    Yerramsetty, Vamsikrishna
    Mohammad, Fayazuddin
    Gupta, Prem Chand
    Atturu, Gnaneswar
    INDIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2022, 9 (05) : 359 - 363
  • [33] Incidence of venous thromboembolism in patients hospitalized with cancer
    Stein, PD
    Beemath, A
    Meyers, FA
    Skaf, E
    Sanchez, J
    Olson, RE
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (01) : 60 - 68
  • [34] Solid cancer, antiphospholipid antibodies, and venous thromboembolism
    Font, Carme
    Vidal, Laura
    Espinosa, Gerard
    Tassies, Dolors
    Monteagudo, Joan
    Farrus, Blanca
    Visa, Laura
    Cervera, Ricard
    Gascon, Pere
    Reverter, Joan C.
    AUTOIMMUNITY REVIEWS, 2011, 10 (04) : 222 - 227
  • [35] Management of recurrent venous thromboembolism in cancer patients
    Romualdi, Erica
    Ageno, Walter
    THROMBOSIS RESEARCH, 2016, 140 : S128 - S131
  • [36] Predicting recurrent venous thromboembolism in cancer: is it possible?
    Kyrle, Paul A.
    THROMBOSIS RESEARCH, 2014, 133 : S17 - S22
  • [37] Cancer genetic alterations and risk of venous thromboembolism
    Mantha, Simon
    Rak, Janusz
    THROMBOSIS RESEARCH, 2022, 213 : S29 - S34
  • [38] Predictive score for estimating cancer after venous thromboembolism: a cohort study
    Ferreyro, Bruno L.
    Angriman, Federico
    Giunta, Diego
    Lourdes Posadas-Martinez, Maria
    Vazquez, Fernando
    Gonzalez Bernaldo De Quiros, Fernan
    Amaral, Andre C. K. B.
    Scales, Damon C.
    BMC CANCER, 2013, 13
  • [39] Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism
    Gran, O. V.
    Braekkan, S. K.
    Paulsen, B.
    Skille, H.
    Rosendaal, F. R.
    Hansen, J-B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (07) : 1361 - 1367
  • [40] The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site
    Mahe, Isabelle
    Chidiac, Jean
    Bertoletti, Laurent
    Font, Carme
    Trujillo-Santos, Javier
    Peris, Marisa
    Perez Ductor, Cristina
    Nieto, Santiago
    Grandone, Elvira
    Monreal, Manuel
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (03) : 337 - 347
12345